Planktonic and sessile susceptibilities to micafungin were determined for 30 clinical isolates of Candida albicans obtained from blood or other sterile sites. Planktonic and sessile MIC 90 s for micafungin were 0.125 and 1.0 g/ml, respectively.
tonic MICs for micafungin ranged from Յ0.03 to 0.25 g/ml (Table 1 ). The MIC 50 and MIC 90 were 0.125 g/ml. The GDH 2346 MIC was 0.06 g/ml.
Sessile MICs (SMICs) were determined with biofilms formed in 96-well, flat-bottomed microtiter plates, as previously described (12) . Organisms were inoculated into 7 ml of yeast nitrogen base medium. After 24 h, they were centrifuged and rinsed twice with phosphate-buffered saline (PBS). After being standardized to 1 ϫ 10 7 CFU/ml in RPMI, 100 l of each suspension was placed in the wells of a 96-well, flat-bottomed microtiter plate and incubated at 37°C. Approximately 24 h later, the suspensions were discarded, and the wells were rinsed three times with sterile PBS and filled with 100 l of micafungin in RPMI. Serial twofold micafungin dilutions ranging from 16 to 0.03 g/ml were studied. Negative-control wells received 100 l RPMI alone. Microtiter plates were incubated at 37°C for an additional 48 h. Then, media were discarded and wells rinsed three times with sterile PBS. A mixture (100 l) of 1:10 menadione (1 mM solution in acetone; Sigma, St. Louis, MO) and 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (1 mg/ml in phosphate-buffer saline; sigma) was then placed into each well. Plates were incubated at 37°C for 2 h. A microtiter plate reader was used to measure each well's absorbance at 492 nm. The lowest concentration associated with a 50% reduction in absorption compared with the level for the control well was reported as the SMIC. SMICs for micafungin were Յ0.03 to 1.0 g/ml for the 30 clinical isolates ( Table 1 ). The SMIC 50 and SMIC 90 were 0.5 to 1.0 g/ml, respectively. The GDH 2346 SMIC was 0.5 g/ml.
We showed that micafungin is active against C. albicans biofilms; its activity cannot necessarily be predicted based on the activity of other echinocandins ( Table 1 ). The seven isolates with caspofungin SMIC values of Ն2 g/ml had anidulafungin SMIC values of Ͻ0.03 g/ml and micafungin SMIC values of Ͻ0.5 g/ml (7). Overall, anidulafungin was the most potent agent against C. albicans biofilms; the anidulafungin SMIC was previously determined to be Յ0.03 g/ml for 28/30 isolates (7). However, the remaining two isolates had anidulafungin SMIC values of Ͼ16 g/ml, one having the highest planktonic anidulafungin MIC (2 g/ml) observed (7) . The two isolates with anidulafungin SMICs of Ͼ16 g/ml had caspo-fungin SMICs of Յ0.25 g/ml and micafungin SMICs of 0.25 g/ml (7, 12) . Together, these data suggest that there may be a need to determine individual echinocandin SMIC values if results are to be translated to the clinical setting.
Choi et al. reported micafungin SMIC values of Յ0.5 g/ml for 12 C. albicans isolates (4). Cateau et al. recently published a study comparing echinocandin treatments of two strains of C. albicans in biofilms on sections of silicone catheters in microtiter plates (2). Exposure to 2 g/ml of caspofungin or 5 g/ml of micafungin for 12 h significantly reduced the metabolic activity of 12-h-and 5-day-old C. albicans biofilms, an effect that was maintained, even 48 h later (2). Finally, Kuhn et al. studied the activity of micafungin against two isolates of C. albicans (including GDH 2346, studied herein) (8) . Planktonic MICs were 0.001 g/ml for both isolates; the SMIC for GDH 2346 was identical to ours, and the SMIC of the second isolate was 0.25 g/ml (8).
Our planktonic MIC findings for micafungin are in accordance with previously published results. A recently published study of 2,869 C. albicans isolates showed that the MIC 90 s were 0.06, 0.06, and 0.03 g/ml for anidulafungin, caspofungin, and micafungin, respectively (11) . In the same study, the highest MICs for anidulafungin, caspofungin, and micafungin were 2, 0.5, and 1 g/ml, respectively (11). There were 12 isolates with anidulafungin MICs of 2 g/ml, which, although considered susceptible based on CLSI breakpoints, is high, given that the modal MIC for this species is 0.3 g/ml; the 12 isolates had micafungin MICs of 0.5 to 1 g/ml (the modal MIC of micafungin was 0.015 g/ml) and caspofungin MICs of 0.12 to 0.25 g/ml (the modal MIC of caspofungin was 0.03 g/ml) (11). Isolates with such high echinocandin MICs have been associated with echinocandin treatment failure (9) . The highest micafungin MIC noted in our study, however, was only 0.25 g/ml (n ϭ 3); these three isolates had anidulafungin MICs of Յ0.03 (n ϭ 2) or 0.06 g/ml and caspofungin MICs of 0.25 (n ϭ 2) or 0.5 g/ml.
Our in vitro studies show that micafungin is active against C. albicans in biofilms.
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